Z-1219-2019Class II
CryoPatch SG Pulmonary Hemi-Artery Patch
Artivion, Inc. / initiated 2016-11-21 / Terminated
CryoLife, Inc. began a recall of CryoPatch SG Pulmonary Hemi-Artery Patch on . FDA classified it as Class II and gives the reason as "The device is recalled due to donor ineligibility of released human tissue. The firm received information that the tissue donor's blood culture tested positive for Enterobacter cloacae". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-1219-2019
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Artivion, Inc.
- Product
- CryoPatch SG Pulmonary Hemi-Artery Patch
- Product code
- DXZ Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene
- Reason for recall
- The device is recalled due to donor ineligibility of released human tissue. The firm received information that the tissue donor's blood culture tested positive for Enterobacter cloacae.
- FDA root cause
- Release of Material/Component prior to receiving test results
- Action
- The firm sent the physician a letter on 11/21/2016.
- Quantity in commerce
- 1
- Distribution
- Product was shipped to Texas
- Product codes and lots
- Model #: SGPHOO Serial #10685466
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-1219-2019 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
